{"DataElement":{"publicId":"3479260","version":"1","preferredName":"Treatment Regimen Intent Type","preferredDefinition":"The value that describes the intent of treatment type.","longName":"TREAT_REG_INT_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2180045","version":"1","preferredName":"Treatment Regimen Intent","preferredDefinition":"information on purpose of the treatment regimen.","longName":"TX_RGM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2224094","version":"1","preferredName":"Treatment_Regimen","preferredDefinition":"Treatment schedule for the pre-clinical trial / therapeutic experiment describing the dosages of the drug and the times of the treatment.","longName":"C15697","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1FF3-7030-5656-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2414894","version":"1","preferredName":"Intent","preferredDefinition":"Intent; an anticipated outcome that is intended or that guides your planned actions.","longName":"C25725","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intent","conceptCode":"C25725","definition":"An anticipated outcome that is the purpose for actions taken, thus guiding the action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E348-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0816AAB-E98E-136F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Swap OC to use caBIG Therapy OC instead","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3479258","version":"1","preferredName":"Treatment Intent Type","preferredDefinition":"The act of administration._Intent; an anticipated outcome that is intended or that guides your planned actions._Something distinguishable as an identifiable class based on common qualities.","longName":"TREAT_INT_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Treatment was given for metastatic disease","valueDescription":"Administration Give For Metastatic Disease or Disorder","ValueMeaning":{"publicId":"3479262","version":"1","preferredName":"Administration Give For Metastatic Disease or Disorder","longName":"3479262","preferredDefinition":"The act of administration.: Transfer possession of something to some person or group.\r\n: The reason of something. : A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Give","conceptCode":"C64974","definition":"Transfer possession of something to some person or group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-AE1C-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26F0B18-AE35-B0E7-E040-BB89AD433AB2","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"},{"value":"Neoadjuvant for primary disease","valueDescription":"Neoadjuvant Therapy For Disease or Disorder","ValueMeaning":{"publicId":"3479259","version":"1","preferredName":"Neoadjuvant Therapy For Disease or Disorder","longName":"3479259","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.: The reason of something. : Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-ADA6-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26F0B18-ADBF-B0E7-E040-BB89AD433AB2","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"},{"value":"Treatment was not given neoadjuvantly or adjuvantly for primary tumor","valueDescription":"Administration Negation Give Neoadjuvant Therapy Adjuvant For Primary Neoplasm","ValueMeaning":{"publicId":"3479261","version":"1","preferredName":"Administration Negation Give Neoadjuvant Therapy Adjuvant For Primary Neoplasm","longName":"3479261","preferredDefinition":"The act of administration.: An operation in which a term denies or inverts the meaning of another term or construction.: Transfer possession of something to some person or group.\r\n: Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.: Agents given to augment or stimulate a primary therapy or alleviate adverse effects caused by the primary therapy.(NCI): The reason of something. : Occurring first in time or sequence; original; of greatest rank or importance or value.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Give","conceptCode":"C64974","definition":"Transfer possession of something to some person or group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-ADF3-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26F0B18-AE0C-B0E7-E040-BB89AD433AB2","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"},{"value":"Adjuvant for primary disease","valueDescription":"Adjuvant For Primary Disease or Disorder","ValueMeaning":{"publicId":"3479263","version":"1","preferredName":"Adjuvant For Primary Disease or Disorder","longName":"3479263","preferredDefinition":"Agents given to augment or stimulate a primary therapy or alleviate adverse effects caused by the primary therapy.(NCI): The reason of something. : Occurring first in time or sequence; original; of greatest rank or importance or value.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-AE44-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26F0B18-AE5D-B0E7-E040-BB89AD433AB2","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3479257","version":"1","preferredName":"Administration Intent Type","preferredDefinition":"The act of administration.:Intent; an anticipated outcome that is intended or that guides your planned actions.:Something distinguishable as an identifiable class based on common qualities.","longName":"C25409:C25725:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intent","conceptCode":"C25725","definition":"An anticipated outcome that is the purpose for actions taken, thus guiding the action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-AD7E-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-AD8F-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"MAESKEB","dateModified":"2012-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Intent of treatment","type":"Preferred Question Text","description":"Intent of treatment","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26F0B18-ADC9-B0E7-E040-BB89AD433AB2","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-06-14","modifiedBy":"MAESKEB","dateModified":"2012-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}